The FDA approved Leukine to treat acute radiation syndrome in the event of a radiological or nuclear emergency in March 2018.
Mandatory Credit: Courtesy Partner Therapeutics
Stories this photo appears in:
Radiation exposure drug maker says it is ramping up supply in Europe
Russia's refusal to rule out nuclear war has put the world in an unsettling reality: The unthinkable is suddenly a possibility -- if extremely remote. One drugmaker, Partner Therapeutics, isn't waiting to take action.
